Among them, we found 12 potential binding sites for homeobox proteins, including two for HOXA9 (Fig. 3A), which, interestingly, we previously showed to present various oncogenic roles and to be a prognostic biomarker in GBM patients (Costa et al., 2010; Pojo et al., 2015). Here, HOXA9 is linked to glioblastoma.